CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...